A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc.
National Cancer Institute (NCI)
Replimune, Inc.
IDEAYA Biosciences
The Netherlands Cancer Institute
Cancer Research UK
Cancer Research UK
Cancer Research UK
Hadassah Medical Organization
Bristol-Myers Squibb
Regeneron Pharmaceuticals
The Christie NHS Foundation Trust
Second Affiliated Hospital of Guangzhou Medical University
Medical University of Graz
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Azienda Sanitaria di Firenze
Laboratorio Pablo Cassará S.R.L.
M.D. Anderson Cancer Center
Leiden University Medical Center
Celgene